These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 31018669)

  • 41. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
    Wang J; Liao L; Tan J
    Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man.
    de Bakker E; Van Ryssen B; De Schauwer C; Meyer E
    Vet Q; 2013 Dec; 33(4):225-33. PubMed ID: 24404887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
    Lin L; Bolund L; Luo Y
    Curr Stem Cell Res Ther; 2016; 11(2):122-30. PubMed ID: 26201862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stem cells as drug delivery methods: application of stem cell secretome for regeneration.
    Tran C; Damaser MS
    Adv Drug Deliv Rev; 2015 Mar; 82-83():1-11. PubMed ID: 25451858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders.
    Viganò M; Sansone V; d'Agostino MC; Romeo P; Perucca Orfei C; de Girolamo L
    J Orthop Surg Res; 2016 Dec; 11(1):163. PubMed ID: 27986082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spheroid Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Microvesicles: Two Potential Therapeutic Strategies.
    Xie L; Mao M; Zhou L; Jiang B
    Stem Cells Dev; 2016 Feb; 25(3):203-13. PubMed ID: 26575103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mesenchymal stem cells and regenerative medicine: future perspectives in osteoarthritis].
    Maumus M; Pers YM; Ruiz M; Jorgensen C; Noël D
    Med Sci (Paris); 2018 Dec; 34(12):1092-1099. PubMed ID: 30623767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal stem cells and their use in therapy: what has been achieved?
    Fernández Vallone VB; Romaniuk MA; Choi H; Labovsky V; Otaegui J; Chasseing NA
    Differentiation; 2013 Jan; 85(1-2):1-10. PubMed ID: 23314286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The application of resveratrol to mesenchymal stromal cell-based regenerative medicine.
    Hu C; Li L
    Stem Cell Res Ther; 2019 Oct; 10(1):307. PubMed ID: 31623691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of Tonsil-Derived Mesenchymal Stem Cells in Tissue Regeneration: Concise Review.
    Oh SY; Choi YM; Kim HY; Park YS; Jung SC; Park JW; Woo SY; Ryu KH; Kim HS; Jo I
    Stem Cells; 2019 Oct; 37(10):1252-1260. PubMed ID: 31287931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non Pregnant Human Uterus as Source of Mesenchymal Stem Cells.
    Eiro N; Fraile M; Schneider J; Vizoso FJ
    Curr Stem Cell Res Ther; 2018; 13(6):423-431. PubMed ID: 29701160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review.
    Przywara D; Petniak A; Gil-Kulik P
    Med Sci Monit; 2024 Aug; 30():e945331. PubMed ID: 39154207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity of mesenchymal stromal/stem cells.
    Chen W; Lv L; Chen N; Cui E
    Scand J Immunol; 2023 Jun; 97(6):e13267. PubMed ID: 39007962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The regenerative medicine in oral and maxillofacial surgery: the most important innovations in the clinical application of mesenchymal stem cells.
    Tatullo M; Marrelli M; Paduano F
    Int J Med Sci; 2015; 12(1):72-7. PubMed ID: 25552921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders.
    Colpo GD; Ascoli BM; Wollenhaupt-Aguiar B; Pfaffenseller B; Silva EG; Cirne-Lima EO; Quevedo J; Kapczinski F; Rosa AR
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1435-49. PubMed ID: 26247151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine.
    Leuning DG; Reinders ME; Li J; Peired AJ; Lievers E; de Boer HC; Fibbe WE; Romagnani P; van Kooten C; Little MH; Engelse MA; Rabelink TJ
    Stem Cells Transl Med; 2017 Feb; 6(2):405-418. PubMed ID: 28191776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs).
    Mazini L; Rochette L; Amine M; Malka G
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The transplantation of mesenchymal stem cells derived from unconventional sources: an innovative approach to multiple sclerosis therapy.
    Giacoppo S; Bramanti P; Mazzon E
    Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):363-379. PubMed ID: 28342084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy.
    Li H; Rong P; Ma X; Nie W; Chen C; Yang C; Zhang J; Dong Q; Wang W
    Life Sci; 2018 Dec; 215():113-118. PubMed ID: 30399376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction.
    Shafei AE; Ali MA; Ghanem HG; Shehata AI; Abdelgawad AA; Handal HR; ElSayed AS; Ashaal AE; Ali MM; El-Shal AS
    J Cell Biochem; 2018 Jul; 119(7):5274-5286. PubMed ID: 29266431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.